Reducing Hereditary Cancer Act of 2021
Latest action · Jun 24, 2021 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedJun 23, 2021
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Reducing Hereditary Cancer Act of 2021
This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.
Cosponsors 56
Members who signed on, in the order they did. Signatures ran from Jun 23, 2021 to Oct 14, 2022; 3 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-MI | Elissa Slotkin | Original | Jun 23, 2021 |
| R-IA | Mariannette Miller-Meeks | Original | Jun 23, 2021 |
| R-IL | Rodney Davis | Original | Jun 23, 2021 |
| R-PA | Brian K. Fitzpatrick | Jul 28, 2021 | |
| D-CT | Jahana Hayes | Aug 6, 2021 | |
| D-TX | Sheila Jackson Lee | Aug 24, 2021 | |
| D-CA | Julia Brownley | Nov 18, 2021 | |
| D-NJ | Jefferson Van Drew | Nov 30, 2021 | |
| D-CT | John B. Larson | Nov 30, 2021 | |
| D-MD | Kweisi Mfume | Dec 1, 2021 | |
| D-FL | Charlie Crist | Dec 7, 2021 | |
| D-CO | Joe Neguse | Dec 7, 2021 | |
| D-VA | A. Donald McEachin | Dec 14, 2021 | |
| D-NH | Ann M. Kuster | Dec 14, 2021 | |
| D-MD | C. A. Dutch Ruppersberger | Dec 14, 2021 | |
| D-FL | Darren Soto | Dec 14, 2021 | |
| D-MD | David J. Trone | Dec 14, 2021 | |
| D-MI | Debbie Dingell | Dec 14, 2021 | |
| D-WA | Derek Kilmer | Dec 14, 2021 | |
| D-CA | Doris O. Matsui | Dec 14, 2021 | |
| D-IL | Janice D. Schakowsky | Dec 14, 2021 | |
| D-FL | Kathy Castor | Dec 14, 2021 | |
| D-TX | Marc A. Veasey | Dec 14, 2021 | |
| D-OH | Marcy Kaptur | Dec 14, 2021 | |
| D-CA | Nanette Diaz Barragán | Dec 14, 2021 | |
| D-CA | Raul Ruiz | Dec 14, 2021 | |
| D-OR | Suzanne Bonamici | Dec 14, 2021 | |
| D-CA | Tony Cárdenas | Dec 14, 2021 | |
| D-NY | Yvette D. Clarke | Dec 14, 2021 | |
| D-MA | Lori Trahan | Dec 23, 2021 | |
| D-AZ | Tom O'Halleran | Dec 23, 2021 | |
| D-CO | Diana DeGette | Jan 19, 2022 | |
| D-CA | Sara Jacobs | Jan 19, 2022 | |
| R-NE | Don Bacon | Feb 18, 2022 | |
| D-FL | Al Lawson, Jr. | Mar 1, 2022 | |
| R-WA | Jaime Herrera Beutler | Mar 15, 2022 | |
| D-NY | Antonio Delgado | Mar 16, 2022 | |
| R-NV | Mark E. Amodei | Mar 16, 2022 | |
| D-CA | Ro Khanna | Mar 30, 2022 | |
| D-NY | Brian Higgins | May 6, 2022 | |
| D-CA | Judy Chu | May 6, 2022 | |
| D-TN | Steve Cohen | May 6, 2022 | |
| D-NY | Joseph D. Morelle | Jun 15, 2022 | |
| D-IN | André Carson | Jul 7, 2022 | |
| D-NJ | Josh Gottheimer | Jul 7, 2022 | |
| D-CA | Salud O. Carbajal | Jul 7, 2022 | |
| R-OH | Bill Johnson | Aug 9, 2022 | |
| R-IN | Larry Bucshon | Aug 9, 2022 | |
| D-NY | Paul Tonko | Aug 9, 2022 | |
| D-CA | Pete Aguilar | Aug 26, 2022 | |
| D-CA | Josh Harder | Sep 13, 2022 | |
| D-MO | Cori Bush | Sep 20, 2022 | |
| R-FL | Neal P. Dunn | Sep 28, 2022 | |
| R-IN | Greg Pence | Sep 29, 2022 | |
| D-WI | Gwen Moore | Oct 4, 2022 | |
| D-MA | Stephen F. Lynch | Oct 14, 2022 |
Committees 2
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Jun 23, 2021 |
| Health Subcommittee | Referred Jun 24, 2021 | |
| House | Ways and Means Committee | Referred Jun 23, 2021 |
| Health Subcommittee | Referred Jun 23, 2021 |
Actions 4
Everything that happened, newest first.
- Jun 24, 2021Referred to the Subcommittee on Health.
- Jun 23, 2021Introduced in House
- Jun 23, 2021Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Jun 23, 2021Referred to the Subcommittee on Health.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 167, no. 109, June 23, 2021, page H3083.
Related bills 2
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 1526 | Reducing Hereditary Cancer Act | Reintroduced Bill | Dec 17, 2024 |
| S 3656 | Reducing Hereditary Cancer Act of 2022 | Related bill | Feb 16, 2022 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend title XVIII of the Social Security Act to provide hereditary cancer genetic testing for individuals with a history of a hereditary cancer gene mutation in a blood relative or a personal or ancestral history suspicious for hereditary cancer, and to provide coverage of certain cancer screenings or preventive surgeries that would reduce the risk for individuals with a germline (inherited) mutation associated with a high risk of developing a preventable cancer.
- Short Title(s) as Introduced
- Reducing Hereditary Cancer Act of 2021
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Jun 23, 2021Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
